Organogenesis' Medical Affairs department serves as a scientific and clinical resource for healthcare professionals through generation and communication of evidence on Organogenesis' innovative products and the therapeutic areas related to them.
Utilizing clinical, scientific, and technical knowledge of wound healing, tissue regeneration, and surgical applications to educate on safe and effective utilization of Organogenesis' products.
Delivering clinically sound, scientifically substantiated, fair-balanced medical information.
Facilitating company-sponsored and investigator-initiated research initiatives, interacting with potential investigators interested in conducting robust preclinical or clinical studies with our products, or in areas of scientific interest to Organogenesis.
Leveraging health economic and outcomes data communicating the favorable impact of Organogenesis products on total cost of care.
Cultivating high-caliber, collaborative relationships and liaising with the experts in the field to develop and advance innovative ideas.
Providing safety input into the pharmacovigilance and risk management processes, ensuring safety throughout the lifecycle of products.